Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammography | 4 | 2018 | 1052 | 0.680 |
Why?
|
| Simulation Training | 1 | 2017 | 162 | 0.500 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 424 | 0.480 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 1379 | 0.440 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 705 | 0.380 |
Why?
|
| Breast | 1 | 2017 | 1369 | 0.370 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 1340 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 7895 | 0.250 |
Why?
|
| Radiographic Image Enhancement | 2 | 2017 | 410 | 0.220 |
Why?
|
| Breast Neoplasms | 4 | 2018 | 16215 | 0.190 |
Why?
|
| False Negative Reactions | 1 | 2018 | 291 | 0.160 |
Why?
|
| Deductibles and Coinsurance | 1 | 2017 | 10 | 0.150 |
Why?
|
| Practice Management, Medical | 1 | 2015 | 19 | 0.130 |
Why?
|
| Mentoring | 1 | 2017 | 105 | 0.120 |
Why?
|
| Radiologists | 1 | 2017 | 178 | 0.120 |
Why?
|
| Insurance Coverage | 1 | 2017 | 275 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2017 | 397 | 0.120 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 1330 | 0.100 |
Why?
|
| Curriculum | 1 | 2017 | 919 | 0.100 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2017 | 1229 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 4048 | 0.080 |
Why?
|
| Clinical Competence | 1 | 2017 | 1325 | 0.080 |
Why?
|
| SUMO-1 Protein | 1 | 2008 | 22 | 0.080 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2008 | 49 | 0.080 |
Why?
|
| Ubiquitins | 1 | 2008 | 95 | 0.080 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2008 | 148 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2017 | 1452 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2018 | 6764 | 0.070 |
Why?
|
| Viral Proteins | 1 | 2008 | 491 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 809 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2018 | 39890 | 0.050 |
Why?
|
| Female | 5 | 2018 | 148940 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 30998 | 0.040 |
Why?
|
| Humans | 7 | 2018 | 270740 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 124 | 0.030 |
Why?
|
| Career Mobility | 1 | 2017 | 89 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 36 | 0.030 |
Why?
|
| Aged | 2 | 2018 | 73333 | 0.030 |
Why?
|
| Organizational Objectives | 1 | 2015 | 66 | 0.030 |
Why?
|
| Career Choice | 1 | 2017 | 210 | 0.030 |
Why?
|
| Texas | 2 | 2017 | 6449 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 5002 | 0.030 |
Why?
|
| Adult | 2 | 2018 | 82040 | 0.030 |
Why?
|
| Leadership | 1 | 2017 | 271 | 0.030 |
Why?
|
| Middle Aged | 2 | 2018 | 90352 | 0.030 |
Why?
|
| Critical Pathways | 1 | 2015 | 160 | 0.030 |
Why?
|
| Workload | 1 | 2015 | 194 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 690 | 0.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2008 | 96 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 631 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 833 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 657 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2008 | 756 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2008 | 636 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2008 | 1192 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 14012 | 0.010 |
Why?
|
| Protein Binding | 1 | 2008 | 3485 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 5338 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 3339 | 0.010 |
Why?
|
| Gene Expression | 1 | 2008 | 3640 | 0.010 |
Why?
|
| United States | 1 | 2017 | 15861 | 0.010 |
Why?
|
| Prognosis | 1 | 2017 | 22505 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 10708 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 61956 | 0.000 |
Why?
|